| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |